A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work — Stella
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(124 sites)
United States
Alabama Neurology Associates- Site Number : 8400019, Homewood, Alabama
USC Norris Comprehensive Cancer Center- Site Number : 8400002, Los Angeles, California
University of California Irvine - Manchester Pavilion- Site Number : 8400007, Orange, California
Yale University School of Medicine- Site Number : 8400018, New Haven, Connecticut
NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024, Glenview, Illinois
University of Kansas Medical Center (KUMC)- Site Number : 8400010, Westwood, Kansas
NeuroMedical Clinic of Central Louisiana- Site Number : 8400031, Alexandria, Louisiana
Ochsner Medical Center - Jefferson Highway- Site Number : 8400030, New Orleans, Louisiana
Johns Hopkins Hospital- Site Number : 8400015, Baltimore, Maryland
Massachusetts General Hospital- Site Number : 8400009, Boston, Massachusetts
Henry Ford Hospital- Site Number : 8400025, Detroit, Michigan
Michigan State University- Site Number : 8400038, East Lansing, Michigan
Argentina
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320002, Buenos Aires
Investigational Site Number : 0320003, Buenos Aires
Belgium
Investigational Site Number : 0560001, Leuven
Brazil
Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760012, Vitória, Espírito Santo
Hospital Sao Rafael- Site Number : 0760011, Salvador, Estado de Bahia
Hospital Moinhos de Vento- Site Number : 0760003, Porto Alegre, Rio Grande do Sul
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760007, Ribeirão Preto, São Paulo
PSEG Centro de Pesquisa Clínica- Site Number : 0760009, São Paulo
Bulgaria
Investigational Site Number : 1000002, Blagoevgrad
Investigational Site Number : 1000001, Pleven
Canada
Investigational Site Number : 1240001, Québec, Quebec
Chile
Investigational Site Number : 1520003, Lo Barnechea, Reg Metropolitana de Santiago
Investigational Site Number : 1520002, Santiago, Reg Metropolitana de Santiago
Investigational Site Number : 1520001, Santiago, Reg Metropolitana de Santiago
China
Investigational Site Number : 1560013, Beijing
Investigational Site Number : 1560010, Beijing
Investigational Site Number : 1560005, Beijing
Investigational Site Number : 1560016, Beijing
Investigational Site Number : 1560009, Changsha
Investigational Site Number : 1560011, Chengdu
Investigational Site Number : 1560002, Fuzhou
Investigational Site Number : 1560012, Guangzhou
Investigational Site Number : 1560007, Guangzhou
Investigational Site Number : 1560014, Hangzhou
Investigational Site Number : 1560008, Jinan
Investigational Site Number : 1560015, Nanchang
Investigational Site Number : 1560001, Shanghai
Czechia
Investigational Site Number : 2030004, Brno
Investigational Site Number : 2030003, Hradec Králové
Investigational Site Number : 2030002, Pardubice
Denmark
Investigational Site Number : 2080002, Aarhus
Investigational Site Number : 2080001, Copenhagen
France
Investigational Site Number : 2500001, Le Kremlin-Bicêtre
Investigational Site Number : 2500003, Lille
Investigational Site Number : 2500002, Marseille
Investigational Site Number : 2500005, Montpellier
Investigational Site Number : 2500004, Paris
Germany
Investigational Site Number : 2760001, Bad Homburg
Investigational Site Number : 2760004, Berlin
Investigational Site Number : 2760007, Bochum
Investigational Site Number : 2760003, Giessen
Investigational Site Number : 2760006, Tübingen
Greece
Investigational Site Number : 3000002, Athens
Investigational Site Number : 3000003, Larissa
Investigational Site Number : 3000001, Thessaloniki
Italy
Investigational Site Number : 3800001, Milan, Milano
Investigational Site Number : 3800009, Rozzano, Milano
Investigational Site Number : 3800006, Rome, Roma
Investigational Site Number : 3800002, Rome, Roma
Investigational Site Number : 3800008, Rome, Roma
Investigational Site Number : 3800007, Messina
Investigational Site Number : 3800003, Palermo
Investigational Site Number : 3800005, Pavia
Investigational Site Number : 3800004, Pisa
Japan
Investigational Site Number : 3920006, Sayama, Osaka
Investigational Site Number : 3920005, Kawagoe, Saitama
Investigational Site Number : 3920014, Yaizu, Shizuoka
Investigational Site Number : 3920011, Bunkyo, Tokyo
Investigational Site Number : 3920008, Kodaira, Tokyo
Investigational Site Number : 3920001, Chiba
Investigational Site Number : 3920003, Fukuoka
Investigational Site Number : 3920009, Saga
Investigational Site Number : 3920013, Tokyo
Mexico
Investigational Site Number : 4840003, Guadalajara, Jalisco
Investigational Site Number : 4840005, Culiacán, Sinaloa
Investigational Site Number : 4840002, Veracruz
Netherlands
Investigational Site Number : 5280001, Amsterdam
Investigational Site Number : 5280002, Rotterdam
Poland
Investigational Site Number : 6160006, Krakow, Lesser Poland Voivodeship
Investigational Site Number : 6160002, Lublin, Lublin Voivodeship
Investigational Site Number : 6160003, Rzeszów, Podkarpackie Voivodeship
Portugal
Investigational Site Number : 6200005, Coimbra
Investigational Site Number : 6200004, Lisbon
Investigational Site Number : 6200001, Lisbon
Investigational Site Number : 6200003, Matosinhos Municipality
South Korea
Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi
Spain
Investigational Site Number : 7240012, Santiago de Compostela, A Coruña [La Coruña]
Investigational Site Number : 7240008, Barcelona, Barcelona [Barcelona]
Investigational Site Number : 7240007, Bilbao, Basque Country
Investigational Site Number : 7240001, Barcelona, Catalunya [Cataluña]
Investigational Site Number : 7240006, Majadahonda, Madrid
Investigational Site Number : 7240003, Pamplona, Navarre
Investigational Site Number : 7240005, Oviedo, Principality of Asturias
Investigational Site Number : 7240009, Sabadell
Investigational Site Number : 7240010, Santa Cruz de Tenerife
Investigational Site Number : 7240002, Valencia
Sweden
Investigational Site Number : 7520001, Stockholm
Taiwan
Investigational Site Number : 1580003, Kaohsiung City
Investigational Site Number : 1580001, Taipei
Investigational Site Number : 1580002, Taipei
Turkey (Türkiye)
Investigational Site Number : 7920006, Ankara
Investigational Site Number : 7920002, Bursa
Investigational Site Number : 7920001, Istanbul
Investigational Site Number : 7920004, Istanbul
Investigational Site Number : 7920003, Konya
Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis, Missouri
Hospital for Special Surgery- Site Number : 8400041, New York, New York
Columbia University Irving Medical Center- Site Number : 8400003, New York, New York
Raleigh Neurology Associates- Site Number : 8400043, Raleigh, North Carolina
University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati, Ohio
University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland, Ohio
Penn State Health Milton South Hershey Medical Center- Site Number : 8400042, Hershey, Pennsylvania
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia, Pennsylvania
Austin Neuromuscular Center- Site Number : 8400040, Austin, Texas
University of Vermont Medical Center- Site Number : 8400012, Burlington, Vermont
University of Virginia- Site Number : 8400023, Charlottesville, Virginia